TABLE 1

Characteristics and adverse events (AEs) of patients treated with 3 months of isoniazid (H) and rifapentine (P)

Patients treated with HP nPatients that reported AEs n
Total3021
Sex
 Male2012
 Female109
Origin
 Europe32
 Africa2016
 Asia/Southeast Asia73
Treatment group
 Migrants2516
 Contacts55
AE grade
 Grade 19
 Grade 28
 Grade 31
 Grade 43

AE grades were as follows. 0: none; 1: mild, <1 month; 2: mild, >1 month; 3: severe, pause in treatment needed; 4: severe, discontinued treatment.